<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02720029</url>
  </required_header>
  <id_info>
    <org_study_id>141751</org_study_id>
    <nct_id>NCT02720029</nct_id>
  </id_info>
  <brief_title>Detection of Silent Aspiration Events Utilizing pH/Impedance Probes in Hospitalized Patients</brief_title>
  <official_title>Detection of Silent Aspiration Events Utilizing pH/Impedance Probes in Hospitalized Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Monitoring and quantification of reflux events in high risk critically ill inpatients and&#xD;
      lower risk general medical/surgical inpatients, with comparison to relevant clinical&#xD;
      variables.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will conduct a pilot prospective cohort study of the incidence of reflux of&#xD;
      gastric contents into the esophagus and the correlation with clinically evident aspiration&#xD;
      events. The investigators will demonstrate that an esophageal multichannel pH/impedance probe&#xD;
      can be used safely and effectively in an inpatient population to monitor reflux of acidic and&#xD;
      non-acidic contents into the esophagus. The investigators will determine the frequency and&#xD;
      severity of reflux events in a 24 hour period in two hospitalized patient populations:&#xD;
      general medicine patients on the wards and critically ill patients in the intensive care&#xD;
      unit. The investigators will then examine the relationship between the documented reflux&#xD;
      events and clinically apparent aspiration events. The incidence of these silent reflux events&#xD;
      in hospitalized patients is currently unclear.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Difficulty with enrollment&#xD;
  </why_stopped>
  <start_date type="Anticipated">December 2016</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of reflux events</measure>
    <time_frame>24 hours</time_frame>
    <description>Summation of acid reflux events and non-acid reflux events over 24hr monitoring period measured by pH change and impedance change detected by the probe</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinically apparent aspiration events</measure>
    <time_frame>Duration of hospitalization, on average 14 days</time_frame>
    <description>Counting clinically apparent aspiration events by way of manual chart review</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Combined aspiration event endpoint</measure>
    <time_frame>Duration of hospitalization, on average 14 days</time_frame>
    <description>Summation of clinically apparent aspiration events, new infiltrates on chest imaging, increase in oxygen requirements, or need for higher level of care due to respiratory decompensation - all components determined by manual chart review</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Acid Aspiration Syndrome</condition>
  <arm_group>
    <arm_group_label>pH/impedance monitor</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>pH/impedance monitor</intervention_name>
    <description>Placement of pH/impedance monitor via the nasogastric route with monitoring for 24 hours, followed by removal.</description>
    <arm_group_label>pH/impedance monitor</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age greater than 18 years&#xD;
&#xD;
          2. Admitted to medical-surgical floor or medical intensive care unit&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with contraindication to nasogastric tube placement (facial trauma, active&#xD;
             epistaxis, abnormal nasopharyngeal or facial anatomy, esophageal stricture or injury,&#xD;
             esophageal varices)&#xD;
&#xD;
          2. Patients requiring non-invasive positive pressure ventilation&#xD;
&#xD;
          3. Patients with uncontrolled vomiting&#xD;
&#xD;
          4. Patients with planned or anticipated airway or esophageal procedure within the 24-hour&#xD;
             monitoring period&#xD;
&#xD;
          5. Patients not expected to survive for 24 hours or those receiving hospice/palliative&#xD;
             care&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joshua P Fessel, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University</affiliation>
  </overall_official>
  <verification_date>January 2018</verification_date>
  <study_first_submitted>March 14, 2016</study_first_submitted>
  <study_first_submitted_qc>March 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 25, 2016</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University</investigator_affiliation>
    <investigator_full_name>Joshua Fessel</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>aspiration</keyword>
  <keyword>reflux</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia, Aspiration</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

